Skip to main content
Log in

Differences between Black and White patients with cancer of the uterine corpus in interval from symptom recognition to initial medical consultation (United States)

  • Research Papers
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

To determine whether Black women with symptoms of uterine corpus cancer had longer times from symptom recognition to initial medical consultation than did White women in the United States, 331 newly diagnosed patients living in Atlanta (GA), New Orleans (LA), and San Francisco/Oakland (CA) during 1985–87 were interviewed to collect information on symptoms, dates of recognition and consultation, and other factors that might affect the interval. Data were analyzed to estimate medical consultation rates and rate ratios following sysptom recognition. Median recalled times between symptom recognition and consultation were 16 days for Black women and 14 days for White women. Although poverty, having no usual source of healthcare, and other factors were associated with lower consultation rates, the adjusted rate among Black women was only somewhat lower (0.87) than among White women, and the 95 percent confidence interval (CI=0.58–1.31) was consistent with no true difference between the races. In addition, the median time to consultation for women with stage IV cancer was only 15 days longer than the time (14 days) for the women with stage I cancer. These results suggest that time from symptom recognition to initial medical consultation does not contribute importantly to the more advanced stage cancer of the uterine corpus commonly found among Black women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Miller BA, Ries LAG, Hankey BF, et al. SEER Cancer Statistics Review: 1973–1990. Rockville, MD (USA): National Cancer Institute, 1993; NIH Pub. No. 93–2789.

    Google Scholar 

  2. Howard J, Hankey BF, Greenberg RS, et al. A collaborative study of black/white differences in cancer patient survival. Cancer 1992; 69: 2350–60.

    Google Scholar 

  3. Fisher ER, Gregorio RM, Fisher B, et al. The pathology of invasive breast cancer: a syllabus derived from findings of the National Surgical Adjuvant Breast Project (Protocol No. 4). Cancer 1975; 36: 1–85.

    Google Scholar 

  4. Gregorio DI, Cummings KM, Michalek A. Delay, stage of disease, and survival among white and black women with breast cancer. Am J Public Helath 1983; 73: 590–3.

    Google Scholar 

  5. Vernon SW, Tilley BC, Neale AV, Steinfeldt L. Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer. Cancer 1985; 55: 1563–71.

    Google Scholar 

  6. Gardner B. The relationship of delay in treatment to prognosis in human cancer. Prog Clin Cancer 1978; 7: 123–33.

    Google Scholar 

  7. Dennis CR, Gardner B, Lim B. Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer. Cancer 1975; 35: 714–20.

    Google Scholar 

  8. Coates RJ, Bransfield DD, Wesley M, et al. Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. JNCI 1992; 84: 938–50.

    Google Scholar 

  9. Wilkinson GS, Edgerton F, Wallace HJ, Reese P, Patterson J, Priore R. Delay, stage of disease and survival from breast cancer. J Chron Dis 1979; 32: 365–73.

    Google Scholar 

  10. Robinson E, Mohilever J, Borovik R. Factors affecting the delay in diagnosis of breast cancer: relationship of delay to stage of disease. Israel J Med Sci 1986; 22: 333–8.

    Google Scholar 

  11. Samet JM, Hunt WC, Lerchen ML, Goodwin JS. Delay in seeking care for cancer symptoms: a population-based study of elderly New Mexicans. JNCI 1988; 80: 432–8.

    Google Scholar 

  12. Richardson JL, Langholz B, Bernstein L, Burciaya C, Danley K, Ross RK. Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer 1992; 65: 922–6.

    Google Scholar 

  13. Liu RJ, Conaway M, Rodriguez G, et al. Poor survival of black women with endometrial cancer is not due to a prolonged interval between the onset of abnormal uterine bleeding and hysterectomy. Gynecol Oncol 1995; 56: 125.

    Google Scholar 

  14. Sheridan B, Fleming J, Atkinson L, Scott G. The effects of delay in treatment on survival rates in carcinoma of the breast. Med J Australia 1971; 1: 262–7.

    Google Scholar 

  15. Interdisciplinary Group for Cancer Care Evaluation in Italy. Reducing diagnostic delay in breast cancer. Cancer 1986; 58: 1756–61.

    Google Scholar 

  16. Worden JW, Weisman AD. Psychosocial components of lagtime in cancer diagnosis. J Psychosomatic Res 1975; 19: 69–79.

    Google Scholar 

  17. MacArthur C, Smith A. Delay in breast cancer and the nature of presenting symptoms. Lancet 1981; 1: 601–3.

    Google Scholar 

  18. Gould-Martin K, Paganini-Hill A, Casagrande C, Mack T, Ross RK. Behavioral and biological determinants of surgical stage of breast cancer. Prev Med 1982; 11: 429–46.

    Google Scholar 

  19. Safer MA, Tharps QJ, Jackson TC, Leventhal H. Determinants of three stages of delay in seeking care at a medical clinic. Med Care 1979; 17: 11–29 1979.

    Google Scholar 

  20. Green LW. Site- and symptom-related factors in secondary prevention of cancer. In: Cullen JW, Fox BH, Martin CR, eds. Cancer: The Behavioral Dimension. New York, NY (USA): Raven, 1976.

    Google Scholar 

  21. Battistella RM. Factors associated with delay in the initiation of physician's care among late adulthood persons. Am J Public Health 1971; 61: 1348–61.

    Google Scholar 

  22. Facione NC. Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay. Soc Sci Med 1993; 36: 1521–34.

    Google Scholar 

  23. American Joint Committee for Cancer Staging and End Results Reporting. Manual for Staging of Cancer 9th Revision. Philadelphia, PA (USA): JP Lippincott, 1992.

    Google Scholar 

  24. International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet 1991; 36: 4–315.

    Google Scholar 

  25. U.S. Department of Health and Human Services. Poverty income guidelines; annual revision. Federal Register 1986; 51: 5105–6.

    Google Scholar 

  26. National Center for Health Statistics. Obese and Overweight Adults in the United States. Hyattsville, MD (USA): National Center for Health Statistics, 1987; DHHS Pub No. 87–1680.

    Google Scholar 

  27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.

    Google Scholar 

  28. Dixon WJ, Brown MB, Engleman L, Hill MA, Jenrich RI. BMDP Statistical Software Manual. Berkeley, CA (USA): University of California Press, 1985.

    Google Scholar 

  29. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Rep 1966; 50: 163–70.

    Google Scholar 

  30. Cox DR. Regression models and life tables. J Stat Soc [B] 1972; 34: 187.

    Google Scholar 

  31. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY (USA): Wiley, 1980.

    Google Scholar 

  32. Mickey RM, Greenland S. The impact of confounding selection criteria on effect estimation. Am J Epidemiol 1989; 129: 125–37.

    Google Scholar 

  33. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993; 138: 937–51.

    Google Scholar 

  34. American Cancer Society. Black Americans' attitudes towards cancer and cancer tests: highlights of a study. CA Cancer J Clin 1981; 31: 212–8.

    Google Scholar 

  35. Price JH, Desmond SM, Wallace M, Smith D, Stewart PM. Difference in black and white adolescents' perceptions about cancer. J School Health 1988; 58: 66–70.

    Google Scholar 

  36. Jepson C, Kessler LG, Portnoy B, Gibbs T. Black-white differences in cancer prevention knowledge and behavior. Am J Public Health 1991; 81: 501–4.

    Google Scholar 

  37. Hill HA, Coates RJ, Austin H, et al. Racial differences in tumor grade among women with endometrial cancer. Gynecol Oncol 1995; 56: 154–63.

    Google Scholar 

Download references

Authors

Additional information

Drs Coates and Eley and Ms Click are with the Department of Epidemiology, Rollins School of Public Health of Emory University, Atlanta, GA (USA). Authors are also with the Division of Cancer Prevention & Control, National Cancer Institute, Rockville, MD (Drs Harlan and Edwards); Department of Pathology Obstetrics and Gynecology, Duke University Medical Center, Durham, NC (Dr Robboy); Forsyth Medical Park, Winston-Salem, NC (Dr Barrett); Environmental Epidemiology Section, California State Department of Health Services, Emeryville, CA (Dr Reynolds); Department of Pathology, Louisiana State University Medical Center, New Orleans, LA (Dr Chen); School of Public Health, University of Massachusetts, Amberst, MA (Dr Darity); Office of the President, Northeastern Ohio Universities College of Medicine, Rootstown, OH (Dr Blacklow). Address correspondence to Dr Coates, Department of Epidemiology, Rollins School of Public Health of Emory University, 1518 Clifton Road, NE, Atlanta, GA 30322, USA. This research was supported in part by contracts N01CN-35042-46, N01CN-05227, N01CN-45174, and N01CN-45176 from the National Cancer Institute, US National Institutes of Health.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coates, R.J., Click, L.A., Harlan, L.C. et al. Differences between Black and White patients with cancer of the uterine corpus in interval from symptom recognition to initial medical consultation (United States). Cancer Causes Control 7, 328–336 (1996). https://doi.org/10.1007/BF00052938

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00052938

Key words

Navigation